Navigation Links
Salk Institute creates Renato Dulbecco Chair in Genomics and Roger Guillemin Chair in Neuroscience
Date:11/29/2010

LA JOLLA, CA-The Salk Institute for Biological Studies today announced the establishment of the Renato Dulbecco Chair in Genomics and the Roger Guillemin Chair in Neuroscience based on an endowment of $6 million from Irwin Jacobs, chairman of the Salk's Board of Trustees, and his wife Joan Klein Jacobs.

"The creation of each chair will pay permanent tribute to the extraordinary research contributions of these two remarkable scientists," said Salk President William R. Brody. "The central roles played by Dr. Dulbecco in genomics and Dr. Guillemin in neuroscience have built a legacy of leadership and innovation that will remain embedded in the Institute now and for years to come."

Renato Dulbecco, M.D., a Founding Fellow of the Salk Institute and President Emeritus, conducted seminal research that provided the first clue to the genetic nature of cancer. He was jointly awarded the 1975 Nobel Prize in Physiology or Medicine for discoveries concerning the interaction between tumor viruses and the genetic material of the cell. In his studies, he described how a virus could insert its own genes into the chromosome of the cell it infects and "turn on" the uncontrolled growth that is the hallmark of cancer. This was the first solid evidence that cancer originates when a cell's genes become mutated, or co-opted, and the breakthrough transformed the way researchers viewed cancer. In 1986, Dulbecco initiated the idea of studying all human genes, helping to launch the worldwide Human Genome Project.

Dr. Dulbecco is the recipient of numerous awards and honors, including the Lasker Award and those given by the National Academy of Sciences, the Royal Society of London and the Academia Del Lincei of Italy. To highlight his achievements, the Salk Institute established the Dulbecco Laboratories for Cancer Research in 2005.

Roger Guillemin, M.D., Ph.D., a distinguished professor and former president of the Salk Institute, won the Nobel Prize in 1977 for discoveries that laid the foundation for brain hormone research. Considered the founder of the field of neuroendocrinology, Guillemin is a scientific pioneer whose work has led to treatments for disorders ranging from infertility to diabetes to pituitary tumors. He discovered an entirely new class of substances that regulate growth, development, reproduction and responses to stress. His discoveries also advanced the study and treatment of a variety of diseases and disorders, including thyroid diseases, infertility, diabetes and several types of tumors.

The beneficiary of countless honors in addition to the Nobel Prize, Guillemin is also a member of the National Academy of Sciences and the American Academy of Arts and Sciences and has received the Lasker Award and the National Medal of Science, among many others. The Institute for Scientific Information lists him as one of the most "highly cited" scientists from 1981-99.

In addition to their profound scientific achievements, Dr. Dulbecco and Dr. Guillemin have each served in leadership roles at the Salk Institute. Dr. Dulbecco was president of the Salk Institute from 1989 to 1992, and Dr. Guillemin served as Interim President from 2007 to 2009.

"Joan and I are particularly pleased to establish these chairs to recognize our two resident Nobel Prize winners, Drs. Dulbecco and Guillemin, for their incredible achievements in science and research, for the leadership they have provided over the years at Salk, and for the legions of scientists they continue to mentor and inspire," said Jacobs.

Joanne Chory, Ph.D., Salk Faculty Chair and holder of the Howard H. and Maryam R. Newman Chair said that the Institute is deeply honored by the couple's generous gift. "Renato and Roger are held in great esteem by their Salk colleagues and their former students. We are indebted to the Jacobs' wonderful generosity in creating these chairs to honor these two extraordinary scientists for their pioneering research and their leadership as former presidents of the Salk Institute."


'/>"/>

Contact: Kat Kearney
kearney@salk.edu
858-453-410-01226
Salk Institute
Source:Eurekalert  

Related biology news :

1. Helmsley Charitable Trust awards more than $15 million to Salk Institute-CUMC
2. Durham Energy Institute to advise government on green technology
3. La Jolla Institute scientist Klaus Ley receives Malpighi award
4. BMC receives National Institutes of Health grant to study intrauterine cocaine and substance reslience
5. The AACR congratulates its members elected to the Institute of Medicine
6. Rutgers part of team awarded $3.3 million National Institutes of Health grant for prostate cancer research
7. Virtual research institute needed to unlock RNAs promise
8. Salk Institute Medals to be awarded to Robert Roeder and Irwin Jacobs
9. Brown Institute for Brain Science marks decade of research impact
10. Cardiovascular Innovation Institute researchers receive over $2 million grant from NIH
11. UCLAs CNSI, Dutch institute sign agreement to collaborate on nanoscience, nanotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Salk Institute creates Renato Dulbecco Chair in Genomics and Roger Guillemin Chair in Neuroscience
(Date:6/15/2016)... New York , June 15, 2016 /PRNewswire/ ... a new market report titled "Gesture Recognition Market by ... and Forecast, 2016 - 2024". According to the report, ... USD 11.60 billion in 2015 and is estimated ... reach USD 48.56 billion by 2024.  ...
(Date:6/2/2016)... 2016 The Department of Transport Management ... 44 million US Dollar project, for the , ... Personalization, Enrolment, and IT Infrastructure , to ... and implementation of Identity Management Solutions. Numerous renowned international vendors ... Decatur was selected for the most compliant and ...
(Date:5/20/2016)... , May 20, 2016  VoiceIt is ... partnership with VoicePass. By working together, ... experience.  Because VoiceIt and VoicePass take slightly different ... engines increases both security and usability. ... excitement about this new partnership. "This ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers ... 5000 and the 6000i models are higher end machines that use the more unconventional ... spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci has ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
Breaking Biology Technology: